2025
First analysis of the Myasthenia Gravis SPOTLIGHT Registry: outcomes with eculizumab and ravulizumab.
Journal of the neurological sciences
鈥�Treats Adults
Michael T Pulley, MD, PhD
Neurologist, Clinical Neurophysiologist, Neuromuscular Medicine Physician
Michael T Pulley, MD, PhD
(904) 383-1022
Request appointment online
Research at a glance
Top areas of exploration
- Myasthenia Gravis , 9 publications
- Amyotrophic Lateral Sclerosis , 5 publications
- Prednisone , 5 publications
- Receptors, Cholinergic , 4 publications
Research activity
My publications
Filter publications
22 publications
2025
Acute adenosine receptor antagonism in combination with acute intermittent hypoxia (AIH) to promote breathing plasticity in Amyotrophic lateral sclerosis: study protocol for a randomized, double-blinded, placebo-controlled trial (Preprint)
JMIR Research Protocols
2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trial.
The Lancet. Neurology
鈥�2025
A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.
Muscle & nerve
鈥�2023
Primary lateral sclerosis natural history study - planning, designing, and early enrollment.
Amyotrophic lateral sclerosis & frontotemporal degeneration
鈥�